Global Microrna Mirna Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 1,173.86 Million |
Market Size (Forecast Year) |
USD 4,178.66 Million |
CAGR |
|
Major Markets Players |
全球微小RNA(miRNA)市场,按研究工具(服务、产品)、应用(癌症、传染病、免疫系统疾病、心血管疾病、神经系统疾病等)、最终用途(生物技术和制药公司、学术和政府研究机构等)划分 - 行业趋势和预测到 2030 年。
MicroRNA(miRNA)市场分析和规模
新兴的用于疾病相关分析应用的 microRNA (miRNA) 工具、miRNA 靶标预测和识别的巨大吸引力以及大多数 miRNA 工具的持续广泛采用都促进了多年来的市场增长。此外,miRNA 是进入商业领域开发未来潜在药物的最重要潜在生物制药候选药物之一。
Data Bridge Market Research 分析,微小 RNA (miRNA) 市场在 2022 年的规模为 11.7386 亿美元,预计到 2030 年将达到 41.7866 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 17.2%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
MicroRNA(miRNA)市场范围和细分
报告指标 |
细节 |
预测期 |
2023 至 2030 年 |
基准年 |
2022 |
历史岁月 |
2021(可定制为 2015 - 2020) |
定量单位 |
收入(百万美元)、销量(单位)、定价(美元) |
涵盖的领域 |
研究工具(服务、产品)、应用(癌症、传染病、免疫系统疾病、心血管疾病、神经系统疾病等)、最终用途(生物技术和制药公司、学术和政府研究机构等) |
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
涵盖的市场参与者 |
Merck KGaA(德国)、QIAGEN(德国)、Thermo Fisher Scientific Inc.(美国)、Synlogic(美国)、GeneCopoeia, Inc(美国)、Horizon Discovery Ltd.(英国)、New England Biolabs(美国)、Quantabio(美国)、NanoString(美国)、BioGenex(美国)、SeqMatic LLC(美国)、Miltenyi Biotec(德国)、Agilent Technologies, Inc(美国)、Promega Corporation(美国)、Abcam plc(英国)、KANEKA CORPORATION(日本) |
市场机会 |
|
Market Definition
MicroRNAs (miRNAs) are endogenous small RNAs that regulate gene expression post-transcriptionally. MiRNA research in allergy is expanding because miRNAs are important regulators of gene expression and promising biomarker candidates. MiRNA mimics and inhibitors are currently in preclinical development as novel therapeutic agents.
Global MicroRNA (miRNA) Market Dynamics
Drivers
- Increasing use of microRNA
The increasing use of microRNA as a biomarker is also propelling the market. These biomarkers are significant in genome-wide population studies and data-driven methods because they have high robustness and reproducibility compared to traditional procedures. As a result, such molecules are promising drug candidate for the development of biomarkers. Furthermore, growing interest in liquid-based biopsies has increased its importance in biomarker discovery and development.
- Surge in research into the potential of miRNA biomarkers
A surge in research into the potential of miRNA biomarkers in prognosis, diagnosis, and therapeutics is expected to favour market expansion in the near future. For instance, in January 2020, researchers used next-generation sequencing to investigate the possibility of miRNA found in peripheral blood as a biomarker for diagnosing Bipolar II disorder (BD-II). MiRNAs could be a noninvasive solution for diagnosing other neurodegenerative diseases.
Opportunities
- Technological innovations
Technological innovation for improving the sensitivity and selectivity of miRNA detection contributes to the microRNA market's growth. Nanoparticle-based amplification, RCA-based, DSN-based, LAMP-based, and enzyme-free amplification are among the newly developed methods for miRNA detection. Similarly, researchers developed a program-based isothermal amplification technique for specific and quantitative digital measurement of miRNA in January 2020. The system can reduce contamination because it is based on signal amplification rather than direct replication of the targeted sequence, as is done with PCR-based approaches.
Restraints/Challenges
- High cost of MicroRNA kits
High cost of microRNA kits and other products will act as a restrain, and further hinder the growth of the microRNA (miRNA) market in the forecast period of 2023-2030.
This microRNA (miRNA) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microRNA (miRNA) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2020, Sistemic Ltd announced the expansion of its patent covering the use of microRNAs as predictive analytes for cellular function. The patent covers microRNA expression analysis of mesenchymal stem cells obtained from various donors to identify miRNAs that will be linked to cellular functions to support donor screening and the development of MSC-based cell therapies.
- In May 2020, DiamiR received U.S. Patent approval for miRNA-based methods for detecting and monitoring brain aging. The patent covers the use of methods for quantitative analysis of detectable miRNA in blood plasma and brain as brain ageing biomarkers.
Global MicroRNA (miRNA) Market Scope
The microRNA (miRNA) market is segmented on the basis of research tool, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Research Tool
- Services
- Sample collection
- Whole blood
- Serum and plasma
- miRNA cDNA synthesis
- Profiling and purification
- Detection
- Functional studies
- NGS
- Microarray
- Real time
- Others
- Products
- Instruments
- Technology
- Real Time PCR
- Microarray
- NGS
- Others
- Workflow
- Isolation & Purification
- Whole Blood
- Serum
- Plasma
- FFPE
- Fresh Frozen Tissue
- Others
- Kits
- Reagents and consumables
- Isolation and purification
- Quantification and detection
- Functional analysis and others
Application
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Diseases
- Neurological Diseases
- Other
End-Use
- Biotechnology
- Pharmaceutical Companies
- Academic
- Government Research Institutes
- Others
MicroRNA (miRNA) Market Regional Analysis/Insights
The microRNA (miRNA) market is analyzed and market size insights and trends are provided by country, research tool, application and end-use as referenced above.
微小RNA(miRNA)市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区(APAC)其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲(MEA)其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于拥有强大的技术支持和完善的研究基础设施,北美在微小RNA(miRNA)市场占据主导地位。
由于基因组研究的快速进步和采用新工具支持研究工作,预计亚太地区将在 2023 年至 2030 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
microRNA (miRNA) 市场还为您提供每个国家/地区资本设备医疗保健支出增长、microRNA (miRNA) 市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对 microRNA (miRNA) 市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。
竞争格局和 MicroRNA (miRNA) 市场份额分析
microRNA (miRNA) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 microRNA (miRNA) 市场的关注有关。
微小RNA(miRNA)市场的一些主要参与者包括:
- 默克集团(德国)
- QIAGEN(德国)
- 赛默飞世尔科技公司(美国)
- Synlogic(美国)
- GeneCopoeia, Inc(美国)
- Horizon Discovery Ltd.(英国)
- 新英格兰生物实验室(美国)
- Quantabio(美国)
- NanoString(美国)
- BioGenex (美国)
- SeqMatic LLC(美国)
- Miltenyi Biotec(德国)
- 安捷伦科技公司(美国)
- Promega 公司 (美国)
- Abcam plc(英国)
- KANEKA株式会社(日本)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.